Evidence map›Paper›PMID 16950925›Full record

ArticleEukaryotic cell2006

Specific inhibition of the plasmodial surface anion channel by dantrolene.

Godfrey Lisk, Myungsa Kang, Jamieson V Cohn, Sanjay A Desai

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. A blasticidin S-resistant Plasmodium falciparum mutant with a defective plasmodial surface anion channel.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Godfrey LiskLaboratory of Malaria and Vector Research, NIAID/NIH, Room 3W-01, 12735 Twinbrook Parkway, Rockville, Maryland 20852-8132, USA.
Myungsa Kang
Jamieson V Cohn
Sanjay A Desai
National Institute of Allergy and Infectious Diseases · US

Funding

The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient AcquisitionZ01AI000882 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI DESAI, SANJAY A · 2001 to 2008
$1.5M
Intramural NIH HHS Z01 AI000882
6 · The paper itself

Abstract

The plasmodial surface anion channel (PSAC), induced on human erythrocytes by the malaria parasite Plasmodium falciparum, is an important target for antimalarial drug development because it may contribute to parasite nutrient acquisition. However, known antagonists of this channel are quite nonspecific, inhibiting many other channels and carriers. This lack of specificity not only complicates drug development but also raises doubts about the exact role of PSAC in the well-known parasite-induced permeability changes. We recently identified a family of new PSAC antagonists structurally related to dantrolene, an antagonist of muscle Ca++ release channels. Here, we explored the mechanism of dantrolene's actions on parasite-induced permeability changes. We found that dantrolene inhibits the increased permeabilities of sorbitol, two amino acids, an organic cation, and hypoxanthine, suggesting a common pathway shared by these diverse solutes. It also produced parallel reductions in PSAC single-channel and whole-cell Cl- currents. In contrast to its effect on parasite-induced permeabilities, dantrolene had no measurable effect on five other classes of anion channels, allaying concerns of poor specificity inherent to other known antagonists. Our studies indicate that dantrolene binds PSAC at an extracellular site distinct from the pore, where it inhibits the conformational changes required for channel gating. Its affinity for this site depends on ionic strength, implicating electrostatic interactions in dantrolene binding. In addition to the potential therapeutic applications of its derivatives, dantrolene's specificity and its defined mechanism of action on PSAC make it a useful tool for transport studies of infected erythrocytes.

Indexed as

AnimalsAnionsAntimalarialsCell Membrane PermeabilityChloridesDantroleneDose-Response Relationship, DrugErythrocyte MembraneHumansIon Channel GatingIon ChannelsMolecular StructureMuscle Relaxants, CentralOocytesOsmotic FragilityPatch-Clamp TechniquesAnionsAntimalarialsChloridesDantroleneIon ChannelsMuscle Relaxants, CentralSorbitol

Identifiers

PMID16950925
PMCPMC1694800
OpenAlexW2162447763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.